methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate

What changed in the last 90 days

Every detected change for methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Osmotic Laxative, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• sodium acetate· in shortage
• sodium bicarbonate· in shortage
• .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, levomefolate calcium, calcium formate, ferrous asparto glycinate, cyanocobalamin, biotin, potassium iodide, magnesium oxide, zinc oxide and cupric oxide· 1 maker
• 0.9% sodium chloride· 1 maker
• 3% sodium chloride· 1 maker
• 50% magnesium sulfate· 1 maker
• abies nig., aesculus hipp., aloe, alumina, bryonia, carbo veg., chelidonium majus, collinsonia , graphites, hydrastis, kali carb., lycopodium, mag. mur., mezereum, nux vom., podoph. pelt., rhamnus purshiana, sanicula, selenium, sepia, silicea, tabacum, veratrum alb., zinc.met., echinacea, iris versicolor, phytolacca, taraxacum· 1 maker
• abrotanum (artemisia abrotanum), anacardium orientale, fucus vesiculosus, helleborus niger, hypothalamus suis, lycopodium clavatum, thymolum, thymus serpyllum, thyroidinum (bovine), glandula suprarenalis suis, hepar suis, pancreas suis, cinchona officinalis, graphites, nicotinamidum, baryta carbonica, calcarea carbonica, calcarea phosphorica, magnesia phosphorica, solidago virgaurea· 1 maker
• abrotanum (artemisia abrotanum), anacardium orientale, fucus vesiculosus, helleborus niger, hypothalamus suis, lycopodium clavatum, thymolum, thymus serpyllum, thyroidinum (bovine), glandula suprarenalis suis, hepar suis, pancreas suis, cinchona officinalis, nicotinamidum, baryta carbonica, calcarea carbonica, calcarea phosphorica, magnesia phosphorica, solidago virgaurea, graphites· 1 maker
• abrotanum, boldo, cimicifuga racemosa, kali phosphoricum, taraxacum officinale, convallaria majalis, magnesia sulphurica, oleander, natrum muriaticum, bellis perennis· 1 maker
• acetaldehyde, aceticum ac, arg nit, caffeinum, calc sulph, citricum ac, cortisone aceticum, echinacea purp, folliculinum, fragaria, fumaricum ac, gallicum ac, glandula suprarenalis suis, hepar suis, histaminum hydrochloricum, hydrangea, lac vac, lecithin, limulus, lycopersicum, lycopodium, nat bicarb, nat mur, nux vom, paraffinum, phosphoricum ac, saccharum off, silicea, tartaricum ac, torula cerevisiae.· 1 maker
• aceticum ac, adrenal gland, arnica, benzoicum ac, ferrum phos, fluoricum ac, ginseng, kali carb, kali lod, kali mur, kali phos, lacticum ac, phosphoricum ac, picricum ac.· 1 maker

Common questions

Is Methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate in shortage right now?

No. FDA does not currently list Methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate?

1 company has marketed Methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.